(Total Views: 195)
Posted On: 09/23/2018 4:09:57 PM
Post# of 87107
Some suggest AGRiMED should look outside the United States, and begin marketing internationally. The biggest market outside the United States is Germany.
Countries like Germany, which embraces the potentially therapeutic effects of cannabidiol oil and dried cannabis, have virtually no domestic growing operations. Thus, they are almost wholly reliant on imports to meet patient and physician demand. So aside from Canada, at present only the Netherlands, Uruguay, Australia (via a recently passed measure), and perhaps soon Israel are in the market of exporting dried cannabis.
Should AGRiMED enter the German market, it would appear to have more than enough export markets at its disposal. However, we should also be concerned that perhaps it would be spreading its distribution system too thin and/or broadening its focus too quickly, which could cause it to miss out on lucrative opportunities, or fail its customers altogether.
For those who wish that UNVC/AGRiMED/SATIVEO would just get moving, because they see other companies jumping ahead and feel we may miss out. Consider first the quality versus quantity dilemma now faced by so many companies on the West Coast. The FDA has clamped on them for mislabeling or for false advertising because they cannot control the quality of the large amounts of cannabis they now raise and market. Today, these companies are tied up in court procedings, and may rue the day they grew so fast.
Countries like Germany, which embraces the potentially therapeutic effects of cannabidiol oil and dried cannabis, have virtually no domestic growing operations. Thus, they are almost wholly reliant on imports to meet patient and physician demand. So aside from Canada, at present only the Netherlands, Uruguay, Australia (via a recently passed measure), and perhaps soon Israel are in the market of exporting dried cannabis.
Should AGRiMED enter the German market, it would appear to have more than enough export markets at its disposal. However, we should also be concerned that perhaps it would be spreading its distribution system too thin and/or broadening its focus too quickly, which could cause it to miss out on lucrative opportunities, or fail its customers altogether.
For those who wish that UNVC/AGRiMED/SATIVEO would just get moving, because they see other companies jumping ahead and feel we may miss out. Consider first the quality versus quantity dilemma now faced by so many companies on the West Coast. The FDA has clamped on them for mislabeling or for false advertising because they cannot control the quality of the large amounts of cannabis they now raise and market. Today, these companies are tied up in court procedings, and may rue the day they grew so fast.
(1)
(0)
